These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8296487)

  • 1. Quantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Humoral immune response enhancement by thymostimulin.
    Fagiolo U; Amadori A; Biselli R; Paganelli R; Nisini R; Cozzi E; Zamarchi R; D'Amelio R
    Vaccine; 1993 Oct; 11(13):1336-40. PubMed ID: 8296487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination.
    Burns EA; Lum LG; L'Hommedieu G; Goodwin JS
    J Gerontol; 1993 Nov; 48(6):B231-6. PubMed ID: 8227990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing immune competence in pigs by immunization with tetanus toxoid.
    Gimsa U; Tuchscherer A; Gimsa J; Tuchscherer M
    Animal; 2018 Jan; 12(1):116-121. PubMed ID: 28554336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific in vivo and in vitro antibody response to tetanus toxoid immunization.
    Ershler WB; Moore AL; Hacker MP
    Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower antibody response to tetanus toxoid associated with higher auto-anti-idiotypic antibody in old compared with young humans.
    Arreaza EE; Gibbons JJ; Siskind GW; Weksler ME
    Clin Exp Immunol; 1993 Apr; 92(1):169-73. PubMed ID: 8467560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization.
    Livingston KA; Jiang X; Stephensen CB
    J Immunol Methods; 2013 Apr; 390(1-2):18-29. PubMed ID: 23318779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
    Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rIL-2 treatment on anti-tetanus toxoid response in the elderly.
    Fagiolo U; Bordin MC; Biselli R; D'Amelio R; Zamarchi R; Amadori A
    Mech Ageing Dev; 1997 Feb; 93(1-3):205-14. PubMed ID: 9089584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses.
    Somani J; Lonial S; Rosenthal H; Resnick S; Kakhniashvili I; Waller EK
    Vaccine; 2002 Dec; 21(3-4):221-30. PubMed ID: 12450697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG; Culbertson NJ
    J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic response to a single dose of tetanus toxoid in older people.
    Shohat T; Marva E; Sivan Y; Lerman I; Mates A; Cohen A
    J Am Geriatr Soc; 2000 Aug; 48(8):949-51. PubMed ID: 10968300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune reaction to tetanus in the elderly: what is the duration of vaccine protection?].
    Steger MM; Maczek C; Berger P; Grubeck-Loebenstein B
    Wien Klin Wochenschr; 1997 Oct; 109(19):767-70. PubMed ID: 9441523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune responses within the human central nervous system following systemic immunization.
    Sandberg-Wollheim M; Zweiman B; Levinson AI; Lisak RP
    J Neuroimmunol; 1986 May; 11(3):205-14. PubMed ID: 3958161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
    Geha RS
    J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of total IgM and IgG and specific IgM and IgG to a thymus-independent (LPS) and a thymus-dependent (tetanus toxoid) antigen in the rat by enzyme-linked immunosorbent assay (ELISA).
    Vos JG; Buys J; Beekhof P; Hagenaars AM
    Ann N Y Acad Sci; 1979 May; 320():518-34. PubMed ID: 110200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.
    Geha RS
    J Immunol; 1983 Apr; 130(4):1634-9. PubMed ID: 6601133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of prophylaxis with chloroquine and proguanil on delayed-type hypersensitivity and antibody production following vaccination with diphtheria, tetanus, polio, and pneumococcal vaccines.
    Gyhrs A; Pedersen BK; Bygbjerg I; Henrichsen J; Heron I; Petersen I; Skinhoj P
    Am J Trop Med Hyg; 1991 Nov; 45(5):613-8. PubMed ID: 1951872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone.
    Samore MH; Siber GR
    Vaccine; 1996 Mar; 14(4):290-7. PubMed ID: 8744555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological memory to tetanus toxoid is established and maintained in the vitamin A-depleted rat.
    Kinoshita M; Pasatiempo AM; Taylor CE; Ross AC
    FASEB J; 1991 Jul; 5(10):2473-81. PubMed ID: 2065894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals.
    Dieye TN; Sow PS; Simonart T; Guèye-Ndiaye A; Popper SJ; Delforge ML; Dieye A; Sarr AD; Crusiaux A; Van Vooren JP; Devleeschouwer M; Kanki P; Mboup S; Diakhate L; Farber CM
    Vaccine; 2001 Dec; 20(5-6):905-13. PubMed ID: 11738756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.